Projects (508)

Sort by: Name | Date

10 | 25 | 50 | 100

1/6

3 A B C D E F G H I J K L M N O P R S T U V W Z All

Zinc transporter antibody - A potential cancer treatment (03/03/2020 - 31/01/2022)

Taylor, Kathryn

Welsh NRN Life Sciences Health Related Biosciences Workshop (01/08/2017 - 31/01/2018)

Brancale, Andrea

Welsh NRN life science drug delivery technology workshop (16/02/2015 - 30/09/2015)

Mcguigan, Christopher

Welsh movement disorder e-Network for patients receiving Rasagiline (01/04/2013 - 31/03/2014)

Welsh Coronavirus Research (W-CoRe): A platform for the discovery of anti-betacoronaviruses agents (15/10/2020 - 31/03/2021)

Brancale, Andrea

Welsh anti-microbial testing platform (01/06/2015 - 31/12/2018)

Brancale, Andrea

Visualisation of biocide effect against Salmonella spp (08/11/2010 - 07/12/2010)

Maillard, Jean-Yves

Visiting Student (01/04/2016 - 31/07/2017)

Simons, Claire

Virucidal and tuberculodial infections (04/04/2016 - 03/04/2019)

Maillard, Jean-Yves

Vector-borne emerging diseases: Computer-aided design synthesis and evaluation of novel antiviral compounds against Chikungunya and Zika viruses (01/12/2016 - 30/11/2019)

Bassetto, Marcella

Validating and explaining the presenting skills assessment for medics (01/07/2014 - 15/12/2018)

Smith, Mathew

UV380 Microbial testing (03/10/2016 - 15/12/2016)

Maillard, Jean-Yves

Utilising permipatch technology for the controlled and targeted delivery of potassium permanganate micro particles to wounds (01/08/2017 - 31/12/2017)

Using biodiversity research as catalyst for community based co-production studies (28/09/2020 - 30/09/2021)

Baillie, Les

Using 'big data' to assess the quality of prescribing and medicines management for elderly care home residents (03/01/2017 - 02/01/2020)

Smith, Mathew

Use of the ex-vivo test to evaluate the efficacy of antimicrobial topical formulations (05/12/2011 - 26/12/2011)

Maillard, Jean-Yves

Use of minimally invasive technology platforms for extraction and delivery of dendritic cell vaccines (01/08/2017 - 31/10/2017)

Birchall, James

Unlicensed �special� medicines: improving the patients� experience (01/04/2018 - 01/09/2021)

Mantzourani, Efthymia

Understanding the risk of emerging bacterial resistance to topical antibiotics (01/04/2019 - 31/08/2019)

Maillard, Jean-Yves

Understanding the risk of emerging bacterial resistance to topical antibiotics (01/01/2020 - 31/12/2022)

Maillard, Jean-Yves

Understanding the resilience of dry environmental microbial biofilms to disinfection (01/10/2018 - 31/03/2022)

Maillard, Jean-Yves

Understanding the interactions of oxidising agents with macromolecules and microbial cell components (01/07/2008 - 01/07/2011)

Maillard, Jean-Yves

Understanding the biomechanics of human skin tissue and micro-disruption of the skin barrier by transdermal delivery systems (TDS) such as the microneedle array device (MD) (01/06/2010 - 31/05/2011)

Coulman, Sion

Understanding the association between E-cadherin loss and adverse response to endocrine agents in ER+ breast cancer (01/01/2015 - 31/01/2016)

Hiscox, Stephen

Understanding how ageing and the female gender contribute to mitochondrial dysfunction and the development of Alzheimer's disease (01/10/2019 - 31/12/2021)

Kidd, Emma

Understanding how age and gender influence the development of Alzheimer's disease (01/10/2018 - 30/09/2021)

Kidd, Emma

Treating progressive multiple sclerosis using a novel neuroprotective and anti-inflammatory approach (01/10/2015 - 15/11/2018)

Mcguigan, Christopher

Translation of bacterial mediated therapeutic RNAi of solid tumours by demonstrating PARP inhibition in preclinical trials (30/06/2018 - 15/11/2018)

Brancale, Andrea

Transfer and embed new knowledge and capabilities that will enable Invatech to exploit the full commercial value of extensive data and information generated and stored by its medicines management system and maximise new commercial market opportunity (23/11/2018 - 27/01/2022)

Smith, Mathew

Towards validation of an immune suppressor protein from liver fluke as a drug target (01/10/2015 - 30/09/2018)

Mcguigan, Christopher

Towards the repurposing of existing topical antimicrobials by ligand complexation (01/10/2015 - 25/01/2019)

Heard, Charles

Towards the commercialisation of dual action mucoadhesive patches to treat periodontal disease (01/02/2017 - 31/01/2018)

Heard, Charles

Towards devising a therapeutic strategy for patients with RRM2B-related mitochondrial (15/06/2018 - 31/07/2021)

Mehellou, Youcef

Towards a nanomedicine-based broad-spectrum topical virucidal therapeutic system (01/10/2007 - 31/01/2011)

Heard, Charles

Towards a magneto-optical sensor for sepsis (01/07/2012 - 26/08/2012)

Allender, Christopher

To reduce microbial contamination on surfaces and infection by developing novel and effective antimicrobial surfaces (21/01/2019 - 17/03/2022)

Maillard, Jean-Yves

To provide analytical and microscopy services analysis of the components of surgical smoke generated by the use of diathermy (01/03/2015 - 30/04/2015)

Birchall, James

Topical delivery of Melatonin Derivatives (01/06/2009 - 30/09/2009)

Heard, Charles

To examine the action of R 1507 in a range of breast cancer models reflective of endocrine response and failure (01/09/2008 - 31/03/2010)

Hutcheson, Iain

To evaluate the in-vitro potential of locally applied antibiotics to cause the development of bacterial resistance (02/01/2018 - 30/09/2018)

Maillard, Jean-Yves

To embed expertise on the development of novel biochemical reagents to pathogens and exploit this knowledge to develop point-of-care products for the healthcare sector (07/06/2010 - 06/06/2012)

Baillie, Les

To develop new biocidal products with efficacy particularly against mycobacteria and non-enveloped viruses (01/11/2016 - 31/12/2019)

Maillard, Jean-Yves

To carry out experiments to investigate the diffusion of budesonide across ocular membranes (01/06/2010 - 31/05/2012)

Allender, Christopher

Tissue engineering for human healing (12/04/2010 - 13/10/2011)

Jones, Arwyn

The use of 3D culture to test the efficacy of a novel enzyme for cancer pro-drug therapy (01/02/2016 - 31/07/2016)

Mcguigan, Christopher

The therapeutic potential of focal adhesion kinase in endocrine-responsive/resistant breast cancer and the HER2+breast cancer subtype (01/11/2010 - 31/07/2012)

Hiscox, Stephen

The sporicidal activity of phoraid against Bacillus anthracis spores (01/02/2010 - 26/03/2010)

Baillie, Les

The sporicidal activity of formalin hydrogen peroxide peracetic acid and bleach against Bacillus anthracis spores (01/06/2010 - 31/03/2011)

Baillie, Les

The role of zinc transporters in cellular zinc signalling (01/08/2010 - 19/09/2015)

Taylor, Kathryn

The role of caveolins in the processing of amyloid precursor protein (01/11/2010 - 29/02/2012)

Kidd, Emma

The role of bacterial toxins in diabetes (01/07/2007 - 30/06/2010)

Wann, Kenneth

The involvement of lipid raft proteins in the processing of amyloid precursor protein (01/03/2012 - 30/06/2015)

Kidd, Emma

The influence of altered endocytic protein expression on the predisposition to develop Alzheimer's disease (08/09/2014 - 30/06/2016)

Kidd, Emma

The identification of B anthracis specific DNA probes (01/02/2015 - 31/10/2015)

Baillie, Les

The GDNF neurosurgical clinical trial: listening to and learning from the participant experience (19/10/2020 - 18/01/2022)

Lane, Emma

The first preclinical analysis for a novel magnetically directed cancer treatment (01/08/2016 - 30/04/2017)

Brancale, Andrea

The discovery of mitochondrial-targeting nucleotide prodrugs for the treatment of mitochondrial diseases (01/01/2019 - 30/04/2019)

Mehellou, Youcef

The design synthesis and evaluation of novel agents acting in the CNS (27/10/2014 - 08/01/2016)

Mcguigan, Christopher

The controlled and targeted release of Potassium permanganates from a matrix into an aqueous interface (01/12/2014 - 30/09/2015)

The controlled and targeted delivery of potassium permanganate micro particles to wounds utilising the permipatch technology (01/10/2016 - 30/09/2017)

The contribution of the exosporium of bacillus anthracis to survival (ROLEEXOSPORIUM) (01/11/2007 - 31/12/2010)

Baillie, Les

The biological evaluation of protide (01/03/2013 - 30/06/2014)

Mcguigan, Christopher

Testng of the activity of Sanytol disinfectant wipes against Pseudononas aeruginosa (01/09/2014 - 30/09/2014)

Maillard, Jean-Yves

Testing the virucidal activity of formulations against poliovirus (01/07/2015 - 31/12/2015)

Maillard, Jean-Yves

Testing the virucidal activity of formulations against poliovirus (01/02/2016 - 29/02/2016)

Maillard, Jean-Yves

Testing the Efficacy of two wipes based on the ASTM 2967-15 (01/07/2016 - 31/07/2016)

Maillard, Jean-Yves

Testing the efficacy of pre-wetted sporicidal wipes (01/09/2016 - 31/10/2016)

Maillard, Jean-Yves

Testing the antimicrobial activity of product (25/09/2017 - 31/12/2017)

Maillard, Jean-Yves

Testing of the sporicidal activity of wipes against Clostridium difficile (29/04/2013 - 02/06/2013)

Maillard, Jean-Yves

Testing of the sporicidal activity of "Schulke" wipe against clostridium difficile (01/09/2012 - 14/09/2012)

Maillard, Jean-Yves

Testing of the sporicidal activity of PDI wipe against clostridium difficile (01/08/2011 - 14/08/2011)

Maillard, Jean-Yves

Testing of the sporicidal activity of 3 new products against clostridium difficle (16/01/2012 - 31/01/2012)

Maillard, Jean-Yves

Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (29/03/2010 - 30/09/2011)

Maillard, Jean-Yves

Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (01/03/2009 - 13/01/2010)

Maillard, Jean-Yves

Testing of the sporiciadal activity of wipes against clostridium difficile (10/04/2012 - 13/04/2012)

Maillard, Jean-Yves

Testing of the propensity of OxyBAC F31 RO (1331) to induce/select/trigger/bacterial resistance (01/07/2014 - 21/07/2014)

Maillard, Jean-Yves

Testing of the propensity of Oxy BAC F31 RO (1331) to induce/select/trigger bacterial resistance (01/12/2014 - 09/02/2015)

Maillard, Jean-Yves

Testing of the new sporicidal activity of 3 new products against clostridium difficile (30/01/2012 - 29/04/2012)

Maillard, Jean-Yves

Testing of the efficacy of Byotrol wipes against two bacterial contaminants (14/05/2012 - 31/05/2012)

Maillard, Jean-Yves

Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (01/09/2012 - 14/09/2012)

Maillard, Jean-Yves

Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (28/01/2013 - 27/02/2013)

Maillard, Jean-Yves

Testing of contamination of Alcoblow(r) (01/04/2013 - 14/04/2013)

Maillard, Jean-Yves

Testing for broad spectrum efficacy of photosensitiser-based formulation (01/01/2020 - 31/12/2020)

Maillard, Jean-Yves

Testing antimicrobial material acitvity (14/09/2015 - 13/01/2016)

Maillard, Jean-Yves

Testing a novel chemotherapy delivery system using two dinitrobenzamide mustard prodrugs (01/10/2015 - 30/09/2018)

Mcguigan, Christopher

Telehealth enabled medicines for care home residents (01/09/2014 - 31/12/2021)

James, Delyth

Technology Transfer Workshop (15/03/2017 - 31/12/2017)

Gumbleton, Mark

Targetting zinc signalling to prevent cell division in cancer (01/10/2015 - 30/09/2018)

Taylor, Kathryn

Targeting zinc signalling to prevent cell division in cancer (01/10/2016 - 30/09/2018)

Taylor, Kathryn

Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01/10/2016 - 15/11/2018)

Brancale, Andrea

Targeting natural products to counter the challenge of MRSA (01/10/2014 - 30/09/2017)

Mcguigan, Christopher

Targeting CtIP to sensitise cancer cells to DNA-damaging agents (01/11/2016 - 31/03/2018)

Brancale, Andrea

Targeted metabolic inhibition of T-lymphocytes: Directing immunity during human disease (01/10/2016 - 15/11/2018)

Brancale, Andrea

Synthetic routes to the tumour proliferation biomarker FLT and ProTide analogues for position emission tomography (PET) imaging (01/01/2010 - 01/01/2013)

Westwell, Andrew

Synthetic routes of 18F labelled gemicitabine and related 2"-fluoronucleotides (01/10/2011 - 30/09/2014)

Westwell, Andrew

Synthesis of novel indole derivatives as apoptosis-inducing antitumour agents (01/01/2007 - 01/01/2010)

Westwell, Andrew

Surfoxidants for universal decontamination (01/07/2019 - 31/10/2019)

Maillard, Jean-Yves

Suldecki - ASM Micro 2019 Conference (01/06/2019 - 02/06/2019)

Maillard, Jean-Yves

Sugar phosphates for osteoarthritis (01/11/2005 - 16/11/2009)

Mcguigan, Christopher

Substrate disinfectant active binding study (01/12/2016 - 30/09/2017)

Maillard, Jean-Yves

10 | 25 | 50 | 100

1/6

Projects (508)

Our policy towards the use of cookies